【Atlas雅思閱讀】AI聊天機器人在心理健康領域的挑戰與倫理

雅思閱讀考題取材非常豐富，Atlas101將不定期分享不同主題的英文文章，幫助大家提升英文實力。這次Atlas101要跟大家分享「老人孤獨死」（Lonely Deaths Among the Elderly）的社會議題，大家看完可以小試身手、回答問題，看看自己答對幾題！！

雅思閱讀考題的主題五花八門，多取材自報章雜誌、書籍等。考生不僅英文程度要好，還要有能力消化各種內容的閱讀理解能力。日常多閱讀英文文章，你將能夠積累更多單字，提升閱讀速度，打開視野，進而在考試中受益匪淺。

Atlas將不定期分享涉及不同主題的英文文章，閱讀完畢後，你可以挑戰文末的判斷題，測試自己的理解程度。看看你是否能正確回答所有問題，這樣一來，你就能確保對文章內容的理解達到100%。

如果你正在準備雅思，想要有專業老師指導你的聽說讀寫，兩個月內提高雅思成績，歡迎加入官方Line＠（＠Atlas101）聯絡我們！

［雅思閱讀］ The Challenges and Ethics of AI Chatbots in Mental Health

The advent of artificial intelligence (AI) chatbots has revolutionized human-computer interaction, providing a platform for open-ended, dynamic conversations. With projections suggesting that the AI chatbot market could reach $1.3 trillion by 2032, these tools offer significant potential in various sectors, including mental health. AI chatbots like ChatGPT, Claude, and Character AI are not only offering personalized advice and entertainment but are also increasingly being utilized to provide emotional support and mental health assistance. However, their integration into the mental health domain brings forth a plethora of challenges, particularly in terms of regulatory oversight and ethical considerations.

人工智慧 (AI) 聊天機器人的出現徹底改變了人機交互，為開放式動態對話提供了平台。根據預測，到 2032 年，人工智慧聊天機器人市場可能達到 1.3 兆美元，這些工具在包括心理健康在內的各個領域提供了巨大的潛力。 ChatGPT、Claude 和 Character AI 等人工智慧聊天機器人不僅提供個人化建議和娛樂，而且越來越多地被用來提供情緒支持和心理健康幫助。然而，它們融入心理健康領域帶來了許多挑戰，特別是在監管監督和道德考慮方面。

AI chatbots have garnered popularity for their ability to deliver complex responses through advanced natural language processing, thereby enhancing mental health support. They provide a cost-effective and stigma-free alternative for individuals seeking help, potentially bridging the gap in accessibility to mental health services. Despite these advantages, the rapid deployment of AI-driven wellness apps highlights significant regulatory gaps, especially in the United States.

人工智慧聊天機器人因其透過先進的自然語言處理提供複雜回應的能力而廣受歡迎，從而增強了心理健康支援。它們為尋求幫助的個人提供了一種具有成本效益且無恥辱的替代方案，有可能縮小獲得心理健康服務的差距。儘管有這些優勢，但人工智慧驅動的健康應用程式的快速部署凸顯了巨大的監管差距，尤其是在美國。

In the U.S., AI chatbots are typically classified under the Food and Drug Administration (FDA)’s distinctions between ‘medical devices’ and ‘general wellness devices.’ Medical devices, which require stringent FDA oversight, are designed to diagnose, treat, or prevent diseases. In contrast, general wellness devices promote a healthy lifestyle without directly addressing medical conditions and thus do not fall under the same rigorous regulatory scrutiny. Consequently, most AI wellness apps evade strict FDA oversight, leading to potential risks when these tools are used for mental health purposes without adequate supervision.

在美國，人工智慧聊天機器人通常根據美國食品藥物管理局 (FDA) 的「醫療設備」和「一般健康設備」的區別進行分類。醫療器材需要 FDA 的嚴格監督，旨在診斷、治療或預防疾病。相較之下，一般健康設備促進健康的生活方式，但不直接解決醫療問題，因此不會受到同樣嚴格的監管審查。因此，大多數人工智慧健康應用程式都逃避 FDA 的嚴格監管，當這些工具在沒有充分監管的情況下用於心理健康目的時，會導致潛在風險。

The FDA’s current regulatory framework struggles to address the complexities of generative AI, which operates autonomously and can behave unpredictably in unanticipated scenarios. This unpredictability is coupled with the opaque nature of AI systems, raising concerns about their potential misuse and the unexpected outcomes that might arise. Therefore, there is a pressing need for updated regulatory approaches that can better manage the risks associated with AI chatbots used in mental health contexts.

FDA 目前的監管框架正在努力解決生成式人工智慧的複雜性，因為生成式人工智慧可以自主運行，並且在不可預見的情況下可能會出現不可預測的行為。這種不可預測性與人工智慧系統的不透明性相結合，引發了人們對其潛在濫用和可能出現的意外結果的擔憂。因此，迫切需要更新監管方法，以更好地管理與在心理健康環境中使用的人工智慧聊天機器人相關的風險。

Moreover, empirical research on AI chatbots in mental health is still in its infancy. Most studies focus on rule-based systems within medical devices, rather than on the more sophisticated conversational AI used in wellness apps. While scripted chatbots have been found to be somewhat effective and safe, they lack the personalized adaptability that human therapists provide. Additionally, the existing research tends to examine technological constraints, such as incorrect outputs and the opacity of “black box” models, rather than exploring user interactions and behaviors comprehensively.

此外，人工智慧聊天機器人在心理健康方面的實證研究仍處於起步階段。大多數研究都集中在醫療設備中基於規則的系統，而不是健康應用程式中使用的更複雜的對話式人工智慧。雖然腳本化聊天機器人被發現在一定程度上有效且安全，但它們缺乏人類治療師提供的個人化適應性。此外，現有的研究傾向於檢查技術限制，例如不正確的輸出和「黑盒子」模型的不透明性，而不是全面探索使用者互動和行為。

Ethical issues also loom large with the use of AI chatbots in mental health. Privacy, transparency, accuracy, safety, and accountability are critical concerns. For instance, the risk of users forming emotional attachments to chatbots, believing them to be more capable than they are, poses significant ethical dilemmas. This phenomenon, known as the ELIZA effect, highlights our tendency to attribute human traits to machines, which can lead to misguided trust and reliance on these tools.

隨著人工智慧聊天機器人在心理健康領域的使用，道德問題也日益突出。隱私、透明度、準確性、安全性和問責制是關鍵問題。例如，使用者對聊天機器人形成情感依戀，認為它們比實際能力更強，這會帶來嚴重的道德兩難。這種現象稱為 ELIZA 效應，凸顯了我們將人類特徵歸因於機器的傾向，這可能導致對這些工具的誤導性信任和依賴。

Furthermore, chatbots’ ability to handle mental health crises is questionable. Studies indicate that AI chatbots frequently mishandle such scenarios, underscoring the need for improved response mechanisms. Ethical frameworks, such as the five-principle model from AI ethics—which includes beneficence, non-maleficence, respect for autonomy, justice, and explicability—can guide the ethical development and deployment of mental health chatbots. However, applying these principles requires careful contextual judgment, especially when they come into conflict.

此外，聊天機器人處理心理健康危機的能力值得懷疑。研究表明，人工智慧聊天機器人經常錯誤地處理此類場景，這凸顯了改進回應機制的必要性。倫理框架，例如人工智慧倫理中的五原則模型——包括仁慈、非惡意、尊重自主、正義和可解釋性——可以指導心理健康聊天機器人的倫理發展和部署。然而，應用這些原則需要仔細的情境判斷，尤其是當它們發生衝突時。

To mitigate the risks and enhance the ethical deployment of AI chatbots in mental health, developers and practitioners must ensure transparency and accountability throughout the technology pipeline. This includes informing users that they are interacting with AI, equipping them with self-help tools, and optimizing the apps’ safety profiles. Additionally, proactive risk assessments by developers and clear regulatory guidance are crucial to balancing innovation with consumer safety.

為了降低風險並加強人工智慧聊天機器人在心理健康領域的道德部署，開發人員和從業者必須確保整個技術管道的透明度和問責制。這包括告知用戶他們正在與人工智慧交互，為他們配備自助工具，以及優化應用程式的安全設定檔。此外，開發商主動進行風險評估和明確的監管指導對於平衡創新與消費者安全至關重要。

In conclusion, while AI chatbots hold promise for expanding access to mental health support, they present significant regulatory and ethical challenges that must be addressed. Ensuring these tools are developed and used responsibly will require a collaborative effort from developers, regulators, and mental health professionals, aimed at safeguarding user welfare while fostering technological innovation.

總之，雖然人工智慧聊天機器人有望擴大獲得心理健康支援的機會，但它們提出了必須解決的重大監管和道德挑戰。確保負責任地開發和使用這些工具需要開發人員、監管機構和心理健康專業人員的共同努力，旨在保障使用者福利，同時促進技術創新。

資料來源一：To chat or bot to chat: Ethical issues with using chatbots in mental health

資料來源二：Chatbots for mental health pose new challenges for US regulatory framework

小試身手：判斷題

看完文章了嗎？下面句子與文章中給出的資訊一致嗎？選擇「True」（符合）、「False」（不符合）或「Not given」（未提及）。

The integration of AI chatbots in mental health support systems has eradicated the stigma associated with seeking psychological help.

AI chatbots used for mental health purposes in the United States are subjected to stringent FDA regulations comparable to those for medical devices.

Generative AI chatbots are designed to operate predictably and consistently across all scenarios.

Current empirical studies extensively cover the user interaction dynamics of AI chatbots in mental health.

The text explicitly details the success rate of AI chatbots in managing mental health crises.

往下看答案↓↓↓↓

↓

正確答案：

The integration of AI chatbots in mental health support systems has eradicated the stigma associated with seeking psychological help.

題目翻譯：在心理支持系統中整合AI聊天機器人後，消除了有關人們尋求心理幫助時的污名化。

答案：TRUE

解析：文章提到 AI 聊天機器人提供了一個無污名的選擇，幫助那些尋求心理健康支持的人，暗示這些工具有助於消除污名。

AI chatbots used for mental health purposes in the United States are subjected to stringent FDA regulations comparable to those for medical devices.

題目翻譯：在美國，與醫療設備相比，用於心理健康目的的AI聊天機器人受到FDA相當嚴格的法規監管。

答案：FALSE
解析：文章明確指出，大多數 AI 健康應用程序逃避嚴格的 FDA 監管，因為它們被歸類為一般健康設備而非醫療設備。